Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Small Cell Lung Carcinoma 9 Urinary Bladder Neoplasms 6 Neoplasms 6 Carcinoma, Hepatocellular 6 Cholangiocarcinoma 5 Biliary Tract Neoplasms 5 Liver Neoplasms 4 Neoplasms by Site 3 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Stomach Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Diseases 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Bronchogenic 2 Carcinoma 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Specimen Handling 4 Nivolumab 4 Biopsy 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 avelumab 1 atezolizumab 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡